Skip to main content

Featured

Carney and Ford’s Steel and Auto Support Package: What It Could Mean for Your Job and Walle

Canadian Money Brief  |  October 21, 2026 Prime Minister Mark Carney and Ontario Premier Doug Ford are set to unveil a joint support package for Canada’s steel, auto and critical-minerals sectors in Ottawa at 2 p.m. ET today . According to QP Briefing , the finance and industry ministers from both governments will join them, and the package is meant to help businesses and workers deal with ongoing trade disruptions. The dollar figures and eligibility rules weren’t public at the time of writing. So here’s what we know, what help already exists, and what to look for when the details land. WHAT WE KNOW SO FAR Who: Carney and Ford, plus both governments’ finance and industry ministers When and where: 2 p.m. ET today, Ottawa Sectors: steel, auto and critical minerals Stated aim: support for businesses and workers affected by trade disruptions Not yet public: total dollars, the federal–Ontario cost split, who qualifies and how to apply Help That’s Already on the Table Today’s p...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment